Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia; and offers OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.

Dr. Thomas Roger Sawyer M.B.A., Ph.D.

Chief Financial Officer, Company Secretary & Director

Mr. Desmond M. Balakrishnan B.A., L.L.B.

Ime	Tržna kapitalizacija
Optomed Oyj	0M
Intrasense SA	0M
Global Health Limited	0M
R1 RCM Inc.	0M
Vaso Corporation	0M
SHL Telemedicine Ltd.	0M
OneLife Technologies Corp.	0M
Beijing Airdoc Technology Co., Ltd.	0M
Health Catalyst, Inc.	0M
TruBridge, Inc.	0M
M3, Inc.	0M

Cognetivity Neurosciences Ltd.

Cognetivity Neurosciences Ltd. Seznam konkurentov

Glavni konkurenti